RDHL Financial Facts

See Full Income Statement

See Full Balance Sheet

RedHill Biopharma (RDHL) Earnings

  |   Expand Research on RDHL
Next EPS Date 5/27/22 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +77.9% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +28.0% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/17/22 Q421 $0.00-$0.33 +$0.33$22.1M$24.08M N/A Details
11/30/21 Q321 -$0.05-$0.21 +$0.16$21.6M$24.52M N/A Details
8/26/21 Q221 -$0.06-$0.12 +$0.06$21.5M$25.02M N/A Details
5/27/21 Q121 -$0.05-$0.34 +$0.29$20.6M$22.7M N/A Details
3/18/21 Q420 $0.00-$0.24 +$0.24N/A$26.03M N/A Details
11/12/20 Q320 $0.05-$0.16 +$0.21$20.9M$25.37M N/A Details
8/13/20 Q220 -$0.04-$0.07 +$0.03$20.9M$22.99M N/A Details
11/19/19 Q319 $0.03-$0.38 +$0.41$1.4M$1.77M N/A Details